HappeningToo topic
Octreotide Acetate reports
Browse community reports connected to Octreotide Acetate. These reports can show that other people are describing similar experiences, but they do not prove that Octreotide Acetate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
40 problems
Abdominal Discomfort while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and abdominal discomfort appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and abdominal distension appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and abdominal pain upper appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and abdominal pain appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and alopecia appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and anxiety appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and back pain appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and chills appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and constipation appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and cough appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and decreased appetite appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and dehydration appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and diarrhea appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and dizziness appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and excessive sweating appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and fatigue appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and feeling abnormal appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and flatulence appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and flushing appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and headache appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and heart rate increased appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hot Flush while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and hot flush appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and hypotension appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and insomnia appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and itching appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and malaise appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and muscle spasms appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and myalgia appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and nausea appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and oropharyngeal pain appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and pain appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and peripheral swelling appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and rash appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and shortness of breath appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and skin redness appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and sleepiness appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and vomiting appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and weakness appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and weight decreased appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Octreotide Acetate
FDA FAERS contains adverse-event reports in which Octreotide Acetate and weight increased appear together. This does not establish that Octreotide Acetate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →